Some unusual analysis just an individual stock - TESLANormally I just make macro index stuff, but today I decided to analyse TESLA stock... here is the picture...
Shortsqueeze
TSLA target
Base on a weekly Gap up, the fast phase of run is in action. logically, it should go 1:1 and hits $16xx , however, from it's starting point of $176.99, 10x would be a great point of guessing, $1769.9!
do not guess top, it would be $17699 if the short squeeze continuous!
BTC- Rise- pullback- liftoffAlmost two months into the uptrend and,it seems that BTC is well into the green zone judging from the weekly timeframe.
Bitmex OI just hits 10 figures, but I want to see a little bit more volume.
Binance OI is rising steadily and long consistently hovers above 50% the past 30 days. We can assume the rise of OI coincides with the rising bullish sentiment.
Overall, volume is rising steadily across all exchanges over the past 30 days which validates the uptrend movement.
Ongoing shorts liquidation at the time of this writing...
I think BTC is due for another pullback to sub 9k area or it may attack 9.8k- 10.3k region, then retraces back to between 8.6k to sub 9k.
Mid -term outlook looks bright for BTC :)
$MNK A Buy On 56% Of The Float Short$MNK is up 40% this week after positive comments from the company's CFO. With a massive short position in the stock, we think this rally has further room to run.
The stock started rallying this week after Chief Financial Officer Bryan Reasons said at the J.P. Morgan Health Care Conference on Monday that the company could pay off its potential 2020 debt maturities, which is a "slightly over" $600 million, in cash. And regarding the dispute with the government over pricing for Acthar, he implied that he was optimistic regarding a favorable outcome, so there was no need to rush to settle. "Right now, we felt like the hearing went really well and we feel good about it," Reasons said, according to a transcript provided by FactSet. "So, we don't feel it's in our best interest to actually initiate the settlements." And regarding the opioid litigations, Chief Executive Mark Trudeau said he was "hopeful" that a resolution can be reached "sooner rather than later." The stock has more than doubled (up 110%) over the past three months, but is still way down 83% off its 52 week high of $27.33 a share.
As always, use protective stops and trade with caution.
Good luck to all!
$JMIA Going To Squeeze The Shorts With 82% Of Float Short$JMIA is on the verge of an epic short squeeze. While the shorts have been right on the money so far, we believe they have overstayed their welcome and are going to be forced to cover.
Yesterday's news:
Jumia (NYSE:JMIA) has named Kenneth Oyolla as its new chief commercial officer, replacing Diana Owusu-Kyereko, according to Business Standard sources.
Owusu-Kyereko was promoted to head Jumia Ghana under the loss-cutting reorganization process.
Oyolla joins from serving in a similar position at Industrial Promotion Services. His prior work history includes stints at Nokia and Unilever.
As always, use protective stops and trade with caution.
Good luck to all!
$SIG About To Squeeze The Shorts33% of the float in $SIG has been sold short. We are expecting a massive short squeeze to fuel $SIG higher. The latest earnings guidance is the catalyst to do so.
Signet Jewelers (NYSE:SIG) reports same store sales were up 1.6% for the two-month holiday period.
Same-store sales for the North America business were up 2.0%.
E-commerce sales rose 13.5% during the holiday period and brick and mortar same store sales were down 0.2%.
Looking ahead, Signet expects FY20 same store sales to rise 0.1% to $6.1B vs. a prior expectation for negative growth. EPS of $3.61 to $3.69 is anticipated vs. $3.26 consensus.
For Q4, Signet sees same-store sales growth of 1.1% and EPS of $3.44 to $3.52 vs. $3.11 consensus.
CEO update: "We delivered holiday same store sales growth ahead of our guidance as we continued to implement year two of our Path to Brilliance transformation. Product newness, investments in our digital capabilities, and more targeted marketing campaigns drove both eCommerce and brick and mortar growth in North America."
As always, trade with caution and use protective stops.
Good luck to all!
$SDC Climbing As Shorts Cover$SDC is a heavily shorted name with plenty of bears. While we aren't going to get into the bull/bear battle over its business, current price action favors the bulls. We think $SDC can easily squeeze to $18 a share. Currently, 21% of the float has been shorted. Watch yesterday's high of $13.88 for confirmation of going higher. The trade should work out immediately if triggered.
As always, use protective stops and trade with caution.
Good luck to all!
$CGC Breaks Out As Expected, More Gains AheadWe said last Thursday that $CGC was on the verge of a breakout and we were right on the money. With 21% of the float short, we expect further short-covering as the shorts get squeezed. We believe the worst is over for $CGC and 2020 is shaping up to be a much better year for cannabis stocks.
Also with the US Presidential election coming up, expect some campaign rhetoric about full marijuana legalization. This will further create optimism around the sector.
As always, use protective stops and trade with caution.
Good luck to all!
$CGC On The Verge Of A Breakout$CGC is a cannabis play that keeps getting more interesting by the day. $CGC is the cannabis name to own with $STZ controlling the company and providing downside protection. Bear in mind that $CGC has a $7 billion market cap and $2 billion in cash. This gives $CGC a lot of fire power as we expect further consolidation to take place after last year's bear market.
Furthermore, 21% of the float has been sold short. We expect short-covering to start happening and drive $CGC higher.
With the stock at $20, our target is $40 and is a stock we are going to take a position in and hold.
Canopy Growth Corporation, together with its subsidiaries, engages in engages in production, distribution, and sale of cannabis in Canada. It operates through two segments, Cannabis Operations and Canopy Rivers. The company’s products include dried flowers, oils and concentrates, softgel capsules, and hemps. It offers its products under the Tweed, Spectrum, DNA Genetics, CraftGrow, Tokyo Smoke, DOJA, Van der Pop, and Maitri brands. The company also provides growth capital and a strategic support platform that pursues investment opportunities in the global cannabis sector. Canopy Growth Corporation has a clinical research partnership with NEEKA Health Canada to investigate the efficacy of cannabinoids for the treatment of post-concussion neurological diseases in former NHL players; partnership with Parent Action on Drugs; and a collaboration with Cure Pharmaceutical Holding Corp. for the development of low-dose cannabidiol oral thin films. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation is headquartered in Smiths Falls, Canada.
As always, use protective stops and trade with caution.
Good luck to all!
Is Tesla Powering Down? Fibonacci Says MaybeTesla's been riding one of the most powerful short squeezes in recent history, more than doubling in short order.
Its last earnings report in October was the spark because the electric-car maker finally overcame big manufacturing problems. While its popular vehicles were never an issue, logistics and manufacturing were an Achilles heel. Now that they're fixed, bears have been running for cover.
But how high can it fly? Some Fibonacci extension lines indicate TSLA might tap the brakes soon.
Let's use the latest daily bull flag December 27-31, with a Trend-Based Fib Extension. Going from the bottom to the top of the flag, it projects a target level around $489 based on the 261.8 percent extension.
TSLA also began the New Year with small gaps on January 2 and 3. Those might look like exhaustion gaps for some technicians.
Finally, the stock is approaching the big round number of $500 which could potentially become psychological resistance.
While there is no telling what happens next with a short squeeze like this, traders looking to buy new shares should know about these levels.
Technical MoveMove appears technical in nature. With short float @ 24M and ≈25% float, 24 days to cover it doesn't take much to induce a short squeeze, which I am assuming someone looked at the chart seeing the MACD was positioned where it was on weekly and that the 50 and 200 DMA had golden cross and took advantage of it. I wouldn't go long on this company due to their balance sheet, but if you're a trader that's risk adverse you could play it.
TSLA @ Record hi & Breaking out of next bull flag! Short SqueezeTesla is killing it on execution and deliveries, short interest has gone down from record highs to 20% but $ value has actually grown by $2.3B to a record because shorts are shorting at much higher prices. Longs are sitting on Fat gains and will not sell by end of year. Shorts will cover to offset other huge gains which will cause more shorts to squeeze.Tesla is also releasing FSD preview in "Holiday Update" by end of year (maybe over the weekend), and Tesla will report Record Delivery numbers on Jan 2/3rd. All Indicators are also triggering buy signals... A Perfect storm. This is about to blow up!!!
$MNK Looks To Be Turning For The Better$MNK has been badly beaten up over the opioid crisis. It's been a favorite of the shorts and they have banked 77% ytd. However, we think judging by the chart, that $MNK has turned the corner and is set to keep climbing. Shorts can help this climb as 55% of the float has been sold short. We could see a massive short covering rally.
The latest news is Mallinckrodt (NYSE:MNK) announces positive findings from a large retrospective study of Acthar Gel in the treatment of the respiratory disease symptomatic sarcoidosis.
The company says analysis of a test of 302 patients showed that the use of Acthar Gel was associated with improved overall health status in 95% of patients as reported by physicians' assessments, with more than half of patients (54%) seeing improvements in two or more symptoms.
Acthar Gel is approved by the FDA for the treatment of symptomatic sarcoidosis.
Mallinckrodt plc, together with its subsidiaries, develops, manufactures, markets, and distributes specialty pharmaceutical products and therapies in the United States, Europe, the Middle East, Africa, and internationally. It operates in two segments, Specialty Brands, and Specialty Generics and Amitiza. The company markets branded pharmaceutical products for autoimmune and rare diseases in the areas of neurology, rheumatology, nephrology, ophthalmology, and pulmonology; and immunotherapy and neonatal respiratory critical care therapies, as well as analgesics and gastrointestinal products. It offers H.P. Acthar Gel, an injectable drug for rheumatoid arthritis, multiple sclerosis, infantile spasms, systemic lupus erythematosus, polymyositis, and others; Inomax, a vasodilator to enhance oxygenation and reduce the need for extracorporeal membrane oxygenation; Ofirmev, an intravenous formulation of acetaminophen for pain management; and Therakos photopheresis, an immunotherapy treatment platform. The company is also developing Terlipressin for the treatment of hepatorenal syndrome; StrataGraft, which is in Phase III and II clinical development for the treatment of burns; Stannsoporfin, a heme oxygenase inhibitor for the treatment of jaundice; Xenon gas for inhalation; MNK-6105 and MNK-6106, an ammonia scavenger for the treatment of hepatic encephalopathy, a neuropsychiatric syndrome associated with hyperammonemia; VTS-270 that is in Phase III development for Niemann-Pick Type C, a neurodegenerative disease; and CPP-1X/sulindac, which is in Phase III development for Familial Adenomatous Polyposis. It markets its branded products to physicians, pharmacists, pharmacy buyers, hospital procurement departments, ambulatory surgical centers, and specialty pharmacies. Mallinckrodt plc has collaboration with the Washington University School of Medicine and Silence Therapeutics plc. The company was founded in 1867 and is based in Staines-Upon-Thames, the United Kingdom.
As always, use protective stops and trade with caution.
Good luck to all!
$BKE Set To Squeeze The Shorts$BKE delivered a strong Q3 earnings report and the stock gapped and made new 52-week highs. With 35% of the float short, we believe $BKE is set to keep climbing as the shorts get squeezed. Here are the highlights from Q3:
Buckle (NYSE:BKE): Q3 GAAP EPS of $0.53 beats by $0.10.
Revenue of $224.12M (+4.2% Y/Y) beats by $6.34M.
Buckle reported a comparable sales increase of 4.7% in Q3.
The company's gross margin also improved to 41.7% of sales vs. 40.1% a year ago and was well ahead of the consensus mark of 38.4%.
Operating margin rose to 14.9% of sales vs. 12.2% a year ago.
The Buckle, Inc. operates as a retailer of casual apparel, footwear, and accessories for young men and women in the United States. It markets a selection of brand name casual apparel, including denims, other casual bottoms, tops, sportswear, outerwear, accessories, and footwear, as well as private label merchandise primarily comprising BKE, Buckle Black, BKE Boutique, Red by BKE, Daytrip denim, Gimmicks, Gilded Intent, FITZ + EDDI, Outpost Makers, Departwest, and Veece. The company also provides services, such as hemming, gift-wrapping, layaways, guest loyalty program, the Buckle private label credit card, and personalized stylist services, as well as special order system that allows stores to obtain requested merchandise from other company stores or its online order fulfillment center. As of February 02-2019, it operated 450 retail stores in 42 states under the Buckle and The Buckle names. The Buckle, Inc. also sells its products through its Website, buckle.com. The company was formerly known as Mills Clothing, Inc. and changed its name to The Buckle, Inc. in April 1991. The Buckle, Inc. was founded in 1948 and is headquartered in Kearney, Nebraska.
As always, use protective stops and trade with caution.
Good luck to all!
$KRTX Will Retrace, Use Fibonacci To Cover$KRTX exploded up the charts on Monday rising 442%. This was clearly a short squeeze and we told our followers as such. After squeezing the shorts, $KRTX is out with an offering and raising money like all biotechs do on a big run. Now, it's the bagholders turn to get screwed over.
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, primarily focuses on developing novel therapies to address disabling neuropsychiatric conditions characterized by significant unmet medical needs. The company’s lead product candidate is KarXT, an oral modulator that is in Phase II clinical trial for the treatment of acute psychosis in patients with schizophrenia, as well as in Phase Ib clinical trial for the treatment of central nervous system disorders, such as cognitive and negative symptoms, Alzheimer’s, and pain. It also focuses on developing other muscarinic-targeted drug candidates. Karuna Pharmaceuticals, Inc. has a license agreement with Eli Lilly and Company; and patent license agreement with PureTech Health LLC. The company was formerly known as Karuna Pharmaceuticals, Inc. and changed its name to Karuna Therapeutics, Inc. in March 2019. Karuna Therapeutics, Inc. was founded in 2009 and is headquartered in Boston, Massachusetts. Karuna Therapeutics, Inc. operates as a subsidiary of PureTech Health plc.
As always, use protective stops and trade with caution.
Good luck to all!
Machine Learning - Algos trying fractal Cup and handle patternsYou can clearly see the difference in terms of relative strength. The market is easy manipulable ... the algos in pattern recognition are squeezing shorts by creating and following previous patterns that are in "vogue" (Inverted IH&S), sort of bullish flag that are in fact a hidden handle in a Cup and Handle pattern and so forth.
Pay attention to the manipulators, do the opposite of your initial thoughts and see if the algos will squeeze by trying new (old) patterns out ....
The market then indeed went back to 5878 after it bounced back from the current low of the day (need to check smaller time frames)
Tesla Cup and Handle Formation setup for Breakout tomorrow!Tesla has formed a nice Big Cup and Handle formation after a Blowout earnings and surprise Profit, while reaffirming its guidance. The Company just announced it will unveil its the Highly Anticipated Cyber Truck in 2 weeks and rumored to start deliveries of its Model 3 out of its Shanghai Gigafactory on Monday Way ahead of schedule. Short interest is massive and they started to squeeze but have pushed the stock down into this Cup and Handle formation. A crazy bullish setup in the MOST SHORTED stock. S&P also just upgraded its Debt from negative to positive yesterday. Tomorrow will be huge and shorts are pressed on friday. Elon Hates them so he is sure to help inflict pain, and has set the stock up with an announcement every week this month to ensure they get squeezed out. Get long.
THE 10K QUESTIONWe are all watching price action, we are all shouting 20K hoping this will move the charts by hope alone. Many traders are looking to make up for the losses from 2017 maybe you bought in at 18K and thought the fudd about 30K Bitcoin was a no brainer....and then reality set in. 2018 was a BLOODY year many people exited the market and will probably never return. we have seen BTC as low ar 3200 dollars in 2019 and in a few weeks, we surpassed the 10K mark, lets pause for a minute. The good news is an investor bought at 3K and in a few weeks tripled their investment, the bad news is the inverse is also true! Now we see BTC shooting up from 7K to the covenant 10k in about 2 days, we can thank China for that one. Looking at the chart I laid out BTC is struggling to break the 10K ceiling (which is good news) volume is down and selling pressure preventing BTC for rallying. This Short squeeze is over and it's my belief that BTC will test the 10k mark any time between now in mid-NOV. I do believe it will break the 10K either in Dec or the first part of 2020 the market is going through a consolidation period and will rally in time. This is not without concern any lessonS to take from 2017 is BTC will nose dive, shake off the weak hands and rally to the moon in a matter of a few weeks. Let's trade carefully and remember Crypto is a highly volatile market and 9500 is not a lot to pay for BTC when it reaches 18K but it's unsettling if BTC goes back to 3K. Take some profits at 10K (thank me later) and set an exit point if BTC takes a downward trend.
BTC bear trap in makingBTC is showing absorption signs at a high timeframe support level.
Agressive sellers getting too comfortable.
Late shorters getting trapped and likely to get punished soon with a move to the upside.
Targeting the 9000 area.
Break and close above 8264 will be the confirmation for the anticipated move.
$TCEL record breaking squeeze can happen here
TCEL $TCEL LOOK AT THE TAPE its not dumping its pure manipulation by a group trying to load cheapies and market makers holding it down. FINRA CUSIP change causes all short positions all naked short positions all positions in general to be closed and accounted for as the TCEL shares will never be traded again the new ticker symbol uses new stock. so if they do not close out then they automatically close so they have been doing everything they can to prevent this from running. my theory is the market makers naked shorted the whole float past year and from the last pop as a reverse split was announced the figured this stock would be dead so they opened positions at .0002-.0003 range they were not expecting a press release to cancel RS and they def were not expecting 400+m .0003’s to get bought in less than 3 minutes and pps ti jump in minutes from .0003-.0006 i would estimate the market makers are in the hole $1.6m thats after subtracting the covering and daytrading trying to get money back. basically any trader would be stupid to sell in this situation if everybody that bought that first day and held this would be at a penny right now. if you look at the tape it says it all. you can clearly see the blatant manipulation market makers are doing and on TCEL its ugly NITE MAXM CSTI GTSM OLMN OTCX are all working together doing coordinated dumps you can see on the tape ever since july 14 there has been coordinated signals disguised as cross trades 37,500 etc to signal to sell down this right here is a major SEC violation. so combined with big groups trying to load up cheap for the run and MM’s trying to push pps down it looks as if its dumps but its not....over half the float is locked up by traders that know whats going on. if nasdaq traders get whiff of whats going on here and they come in and make MM cover their naked shorts we will have a squeeze that will be very memorable. at $0.002 MM will be in the hole $3.6m
$0.008 $14m
$0.01 $17m
thats counting in them day trading it the best they can to cover
all this needs is big money or nasdaq boys to come in n push hard and fast catch the mm offguard same way 3-4-5’s were took someone needs to come in n clear .001’s with one huge slap then clear .002’s with huge slaps n this baby will then be in squeeze mode
ADVAXIS Bullish Stock Chart (ADXS)A few days ago ADXS spiked to 60 cents premarket. But it closed at 44 cents. Now it's presently oversold and looking to bounce back to the resistance levels. The Enterprise Value to EBITDA is 0.55 so I think 50 cents is a realistic target to get to. Buying anywhere below 36 cents is a great deal as it's the first and least difficult resistance level to break.
